trending Market Intelligence /marketintelligence/en/news-insights/trending/uQYl01rMSuig6VwX44B0lw2 content esgSubNav
In This List

Stellar Biotechnologies expands board

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Stellar Biotechnologies expands board

Stellar Biotechnologies Inc. added Charles Olson and Paul Chun to its board of directors.

Olson is Anthera Pharmaceuticals Inc.'s chief technology officer and a biotechnology consultant for Compass Biotechnology LLC. He has been a member of Stellar's scientific advisory board since June 2014.

Chun is managing partner and founder of life sciences-focused advisory company Eldred Advisors LLC.